Cancer

Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily caused by human papillomavirus (HPV), a viral infection that spreads through sexual contact.This article was […]

A new type of cancer cell that “warrants urgent investigation” has been discovered in childhood leukemia and could impact clinical care. Research into new or repurposed treatments that target this new cell type could give […]

Colorectal cancer precursor lesions are benign growths that can develop into colorectal cancer (CRC) over time, through either a conventional or serrated pathway. Understanding how the immune system reacts to these precursor lesions could further […]

Cancer Center at Illinois (CCIL) Program Leader Erik Nelson’s lab made an important discovery about the relationship between cholesterol and breast cancer progression with crucial implications for breast cancer therapeutics.This article was originally published on […]

A new study from the Icahn School of Medicine at Mount Sinai helps explain why some people with multiple myeloma, a type of blood cancer, stay in remission for many years after receiving CAR T […]

Researchers from the University of Sheffield, working in collaboration with Fiocruz-Bahia in Brazil, are shedding new light on a mysterious process known as tumor cell cannibalism, where one cancer cell engulfs another in order to […]

For more than a year, Diane Hunter, now 72, had been experiencing vague symptoms—pain in her spine and hips, nausea, exhaustion, thirst, and frequent urination. Her primary care physician had ruled out diabetes before finally […]

Lung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in screening, surgery and personalized treatment are helping more patients live longer.This article was […]

Researchers at the University of Southampton have identified a new subtype of lymphoma that could pave the way to improved and more targeted treatments for some blood cancer patients. The cancer scientists and biologists have […]

New clinical research has identified a blood test that can reveal which women are more likely to respond to a particular treatment for ovarian cancer, known as PARP inhibitor therapy.This article was originally published on […]